0.49Open0.49Pre Close0 Volume2 Open Interest12.50Strike Price0.00Turnover53.99%IV3.84%PremiumJan 17, 2025Expiry Date0.01Intrinsic Value100Multiplier12DDays to Expiry0.48Extrinsic Value100Contract SizeAmericanOptions Type-0.4782Delta0.3225Gamma25.49Leverage Ratio-0.0198Theta-0.0020Rho-12.19Eff Leverage0.0091Vega
Indivior Stock Discussion
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced preliminary Q3 2024 financial results and provided updated FY 2024 guidance.
• Group now sees lower than expected Q3 2024 and FY 2024 SUBLOCADE net revenue (NR) from a combination of faster initial adoption among treatment providers of the...
No comment yet